The B cell signature can also be modified by miR-29c, which was reduced in B cells of patients with LN, through its predicted gene targets including tumor necrosis factor (TNF), IL-6 and B-cell activating factor (BAFF) [39]. Here, IL6 is linked to lobular neoplasia.